fbpx

ThermoGenesis Holdings to Delay Second Quarter 2020 Earnings Release and Conference Call Until Friday August 14, 2020

RANCHO CORDOVA, Calif., Aug. 11, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced it will delay its second quarter earnings release and conference call for the quarter ended June 30, 2020, previously scheduled for Wednesday, August 12, … Continued

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2020 and Provide a Corporate Strategic Update

Conference Call to be Held on August 12, 2020 RANCHO CORDOVA, Calif., August 5, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2020 … Continued

How COVID-19 Testing Works

COVID-19 tests have proven to be crucial in measuring the spread of the novel coronavirus (SARS-CoV-2) and helping us better understand how to navigate the current global pandemic. Testing has received a large amount of media attention in recent months, but the information has not always been clear.  The most frequent misconception is that there … Continued

Coronavirus Myths – Fact vs. Fiction

Since the Coronavirus pandemic began, we’ve been bombarded with endless and often competing information. In the ensuing months, the internet, and social media in particular, has been a place where many have gotten their news. Some of that information has been useful, while some of it has just been conspiracy theories and outright false claims. … Continued

ThermoGenesis Announces Corning’s Commercial Launch of the X-SERIES® Cell Processing Products Developed by ThermoGenesis

Innovative Density Gradient Media-Free & Buoyancy-Activated Cell Sorting (BACS) Technologies Improve Manufacturing Efficiency and Yield of Cell & Gene-Therapy Products   RANCHO CORDOVA, Calif., June 23, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that, pursuant to its existing, … Continued

ThermoGenesis to Join Russell Microcap® Index

RANCHO CORDOVA, Calif., June 16, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Company is set to join the Russell Microcap® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market … Continued

ThermoGenesis Announces Filing of Patent Applications for Device that Improves the Accuracy of Lateral Flow Immunoassays (LFIA) in the Detection of COVID-19 Antibodies

RANCHO CORDOVA, Calif., June 11, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Company has filed patent applications for a point-of-care device which improves the speed and accuracy of lateral flow immunoassays (LFIA) to detect COVID-19 IgM … Continued

ThermoGenesis Announces That Results of ImmuneCyte’s Licensed Neutralizing Antibody Therapeutics for COVID-19 Were Published in bioRxiv

RANCHO CORDOVA, Calif., June 8, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, the research partner of ThermoGenesis’ joint venture, ImmuneCyte, Inc., published the … Continued

© 2020 ThermoGenesis Corp.
How may we help?